Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia

Steven P. Treon; Andrew R. Branagan; Leukothea Ioakimidis; Jacob D. Soumerai; Christopher J. Patterson; Barry Turnbull; Parveen Wasi; Christos Emmanouilides; Stanley R. Frankel; Andrew Lister; Pierre Morel; Jeffrey Matous; Stephanie A. Gregory; Eva Kimby

doi:10.1182/BLOOD-2008-09-177329

Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia

Steven P. Treon
, Andrew R. Branagan
, Leukothea Ioakimidis
, Jacob D. Soumerai
, Christopher J. Patterson
, Barry Turnbull
, Parveen Wasi
, Christos Emmanouilides
, Stanley R. Frankel
, Andrew Lister
, Pierre Morel
, Jeffrey Matous
, Stephanie A. Gregory
, Eva Kimby

Harvard University
BioBridges, Boston, MA;
McMaster University
University of California, Los Angeles
University of Maryland, Baltimore
St Bartholomew's Hospital
Clinical Hematology, Centre Hospitalier Schaffner, Lens, France;
Rocky Mountain Cancer Center, Denver, CO;
Rush University Medical Center
Karolinska Institutet

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	113
Issue number	16
DOIs	https://doi.org/10.1182/BLOOD-2008-09-177329
State	Published - Nov 16 2008
Externally published	Yes

Disciplines

Medicine and Health Sciences
Gastroenterology
Surgery
Internal Medicine

Access to Document

10.1182/BLOOD-2008-09-177329License: Unspecified

Cite this

@article{60bdbfe2e3bd4f29bda39086af139aca,

title = "Long-term outcomes to fludarabine and rituximab in Waldenstr{\"o}m macroglobulinemia",

author = "Treon, \{Steven P.\} and Branagan, \{Andrew R.\} and Leukothea Ioakimidis and Soumerai, \{Jacob D.\} and Patterson, \{Christopher J.\} and Barry Turnbull and Parveen Wasi and Christos Emmanouilides and Frankel, \{Stanley R.\} and Andrew Lister and Pierre Morel and Jeffrey Matous and Gregory, \{Stephanie A.\} and Eva Kimby",

note = "Steven P. Treon, Andrew R. Branagan, Leukothea Ioakimidis, Jacob D. Soumerai, Christopher J. Patterson, Barry Turnbull, Parveen Wasi, Christos Emmanouilides, Stanley R. Frankel, Andrew Lister, Pierre Morel, Jeffrey Matous, Stephanie A. Gregory, Eva Kimby; Long-term outcomes to fludarabine and rituximab in Waldenstr{\"o}m macroglobulinemia. 2009; 113 (16): 3673-3678.",

year = "2008",

month = nov,

day = "16",

doi = "10.1182/BLOOD-2008-09-177329",

language = "American English",

volume = "113",

journal = "Blood",

publisher = "American Society of Hematology",

number = "16",

}

TY - JOUR

T1 - Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia

AU - Treon, Steven P.

AU - Branagan, Andrew R.

AU - Ioakimidis, Leukothea

AU - Soumerai, Jacob D.

AU - Patterson, Christopher J.

AU - Turnbull, Barry

AU - Wasi, Parveen

AU - Emmanouilides, Christos

AU - Frankel, Stanley R.

AU - Lister, Andrew

AU - Morel, Pierre

AU - Matous, Jeffrey

AU - Gregory, Stephanie A.

AU - Kimby, Eva

N1 - Steven P. Treon, Andrew R. Branagan, Leukothea Ioakimidis, Jacob D. Soumerai, Christopher J. Patterson, Barry Turnbull, Parveen Wasi, Christos Emmanouilides, Stanley R. Frankel, Andrew Lister, Pierre Morel, Jeffrey Matous, Stephanie A. Gregory, Eva Kimby; Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia. 2009; 113 (16): 3673-3678.

PY - 2008/11/16

Y1 - 2008/11/16

UR - http://www.bloodjournal.org/content/bloodjournal/113/16/3673.full.pdf

U2 - 10.1182/BLOOD-2008-09-177329

DO - 10.1182/BLOOD-2008-09-177329

M3 - Article

VL - 113

JO - Blood

JF - Blood

IS - 16

ER -

Long-term outcomes to fludarabine and rituximab in Waldenström macroglobulinemia

Disciplines

Access to Document

Other files and links

Cite this